BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24598749)

  • 1. Structural and thermodynamic basis of the inhibition of Leishmania major farnesyl diphosphate synthase by nitrogen-containing bisphosphonates.
    Aripirala S; Gonzalez-Pacanowska D; Oldfield E; Kaiser M; Amzel LM; Gabelli SB
    Acta Crystallogr D Biol Crystallogr; 2014 Mar; 70(Pt 3):802-10. PubMed ID: 24598749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying Structural Determinants of Product Specificity in
    Maheshwari S; Kim YS; Aripirala S; Murphy M; Amzel LM; Gabelli SB
    Biochemistry; 2020 Jul; 59(29):2751-2759. PubMed ID: 32584028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of nitrogen-containing bisphosphonates (N-BPs) to the Trypanosoma cruzi farnesyl diphosphate synthase homodimer.
    Huang CH; Gabelli SB; Oldfield E; Amzel LM
    Proteins; 2010 Mar; 78(4):888-99. PubMed ID: 19876942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characterization of a lepidopteran type-II farnesyl diphosphate synthase from the spruce budworm, Choristoneura fumiferana: Implications for inhibitor design.
    Picard MÈ; Nisole A; Béliveau C; Sen S; Barbar A; Shi R; Cusson M
    Insect Biochem Mol Biol; 2018 Jan; 92():84-92. PubMed ID: 29183817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.
    Kavanagh KL; Guo K; Dunford JE; Wu X; Knapp S; Ebetino FH; Rogers MJ; Russell RG; Oppermann U
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7829-34. PubMed ID: 16684881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights about the structure of farnesyl diphosphate synthase (FPPS) and the activity of bisphosphonates on the proliferation and ultrastructure of Leishmania and Giardia.
    Gadelha APR; Brigagao CM; da Silva MB; Rodrigues ABM; Guimarães ACR; Paiva F; de Souza W; Henriques C
    Parasit Vectors; 2020 Apr; 13(1):168. PubMed ID: 32248823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of insect isoprenoid biosynthesis with pyridinium bisphosphonates.
    Sen SE; Wood L; Jacob R; Xhambazi A; Pease B; Jones A; Horsfield T; Lin A; Cusson M
    Insect Biochem Mol Biol; 2015 Aug; 63():113-23. PubMed ID: 26073627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ternary complex structures of human farnesyl pyrophosphate synthase bound with a novel inhibitor and secondary ligands provide insights into the molecular details of the enzyme's active site closure.
    Park J; Lin YS; De Schutter JW; Tsantrizos YS; Berghuis AM
    BMC Struct Biol; 2012 Dec; 12():32. PubMed ID: 23234314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutants.
    Tsoumpra MK; Muniz JR; Barnett BL; Kwaasi AA; Pilka ES; Kavanagh KL; Evdokimov A; Walter RL; Von Delft F; Ebetino FH; Oppermann U; Russell RGG; Dunford JE
    Bone; 2015 Dec; 81():478-486. PubMed ID: 26318908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesyl pyrophosphate synthase is essential for the promastigote and amastigote stages in Leishmania major.
    Mukherjee S; Basu S; Zhang K
    Mol Biochem Parasitol; 2019 Jun; 230():8-15. PubMed ID: 30926449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural characterization of substrate and inhibitor binding to farnesyl pyrophosphate synthase from Pseudomonas aeruginosa.
    Schmidberger JW; Schnell R; Schneider G
    Acta Crystallogr D Biol Crystallogr; 2015 Mar; 71(Pt 3):721-31. PubMed ID: 25760619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of a potent phenylalkyl bisphosphonate inhibitor bound to farnesyl and geranylgeranyl diphosphate synthases.
    Cao R; Chen CK; Guo RT; Wang AH; Oldfield E
    Proteins; 2008 Nov; 73(2):431-9. PubMed ID: 18442135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches for Designing new Potent Inhibitors of Farnesyl Pyrophosphate Synthase.
    Rodriguez JB; Falcone BN; Szajnman SH
    Expert Opin Drug Discov; 2016; 11(3):307-20. PubMed ID: 26781029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxodione and arenarone inhibit farnesyl diphosphate synthase by binding to the isopentenyl diphosphate site.
    Liu YL; Lindert S; Zhu W; Wang K; McCammon JA; Oldfield E
    Proc Natl Acad Sci U S A; 2014 Jun; 111(25):E2530-9. PubMed ID: 24927548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The farnesyl-diphosphate/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates.
    Ling Y; Li ZH; Miranda K; Oldfield E; Moreno SN
    J Biol Chem; 2007 Oct; 282(42):30804-16. PubMed ID: 17724033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing the intracellular isoprenoid pool in Saccharomyces cerevisiae by structural fine-tuning of a bifunctional farnesyl diphosphate synthase.
    Rubat S; Varas I; Sepúlveda R; Almonacid D; González-Nilo F; Agosin E
    FEMS Yeast Res; 2017 Jun; 17(4):. PubMed ID: 28854674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enthalpy versus entropy-driven binding of bisphosphonates to farnesyl diphosphate synthase.
    Yin F; Cao R; Goddard A; Zhang Y; Oldfield E
    J Am Chem Soc; 2006 Mar; 128(11):3524-5. PubMed ID: 16536518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-state NMR, crystallographic, and computational investigation of bisphosphonates and farnesyl diphosphate synthase-bisphosphonate complexes.
    Mao J; Mukherjee S; Zhang Y; Cao R; Sanders JM; Song Y; Zhang Y; Meints GA; Gao YG; Mukkamala D; Hudock MP; Oldfield E
    J Am Chem Soc; 2006 Nov; 128(45):14485-97. PubMed ID: 17090032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption.
    Sanders JM; Song Y; Chan JM; Zhang Y; Jennings S; Kosztowski T; Odeh S; Flessner R; Schwerdtfeger C; Kotsikorou E; Meints GA; Gómez AO; González-Pacanowska D; Raker AM; Wang H; van Beek ER; Papapoulos SE; Morita CT; Oldfield E
    J Med Chem; 2005 Apr; 48(8):2957-63. PubMed ID: 15828834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: implications for drug design.
    Gabelli SB; McLellan JS; Montalvetti A; Oldfield E; Docampo R; Amzel LM
    Proteins; 2006 Jan; 62(1):80-8. PubMed ID: 16288456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.